Stockscreener 앱 받기
2.50
14.16%
0.31
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis: Pioneering the Future of Robotic Cardiology Amid Strategic Momentum - AInvest
Does Stereotaxis Inc. show high probability of reboundFree Weekly Watchlist of High Movers - Newser
Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum - MSN
Forecasting Stereotaxis Inc. price range with options dataFree Day Trading Signals With High Precision - Newser
Intraday pattern recognizer results for Stereotaxis Inc.Strong Buy Signal Summary with Entry Zone - Newser
Historical volatility pattern of Stereotaxis Inc. visualizedFree Daily Smart Money Movement Monitor - Newser
Regression analysis insights on Stereotaxis Inc. performanceFree Triple Digit Growth Focused Trade Plan - Newser
What makes Stereotaxis Inc. stock price move sharplyBuy and Hold Position Summary Review - Newser
Should I buy Stereotaxis Inc. stock before earningsFree Weekly Setup With 3x Return Potential - Newser
Stereotaxis Reports Double-Digit Revenue Growth for 2025 Amidst New Catheter Launches - AInvest
Stereotaxis (STXS): A Robotics-Driven Inflection Point in 2025 - AInvest
Is Stereotaxis Inc. a Top Dividend Stock to Watch in 2025Buy Candidate Summary Based on Fundamentals - Newser
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts - Investing.com
Best data tools to analyze Stereotaxis Inc. stockFree Weekly Hot Picks With Buy Confidence - Newser
Stereotaxis Inc. recovery potential after sell offLow Risk Trade Timing with Analysis Metrics - Newser
Stereotaxis Q2 2025 Earnings: Revenue Surges to $8.8 Million, EPS of -$0.05 Beats Estimates. - AInvest
Stereotaxis Inc (STXS) Q2 2025 Earnings Call Highlights: Impressive Revenue Surge and Strategic Advancements - GuruFocus
Stereotaxis reports Q2 EPS (5c), consensus (6c) - TipRanks
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Stereotaxis earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Unlocking Value in Stereotaxis: A High-Growth Medical Tech Play in a Resilient Sector - AInvest
Stereotaxis Reports 2025 Second Quarter Financial Results - GlobeNewswire
Stereotaxis Reports Massive 95% Revenue Jump as New FDA-Cleared Robotic Catheter Drives Growth - Stock Titan
Will Stereotaxis Inc. see short term momentumAI Generated Momentum Stock Forecast Guide - Newser
Does Stereotaxis Inc. stock perform well during market downturnsUnbelievable profit margins - Jammu Links News
What drives Stereotaxis Inc. stock pricePhenomenal returns - Jammu Links News
How strong is Stereotaxis Inc. company’s balance sheetAccelerated investment success - Jammu Links News
What are analysts’ price targets for Stereotaxis Inc. in the next 12 monthsUnprecedented profit potential - Jammu Links News
Should I hold or sell Stereotaxis Inc. stock in 2025Maximize returns with disciplined trading - Jammu Links News
How does Stereotaxis Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Stereotaxis Inc. Stock Analysis and ForecastDynamic profit expansion - Jammu Links News
What is Stereotaxis Inc. company’s growth strategyRapidly growing investment returns - Jammu Links News
Is Stereotaxis Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
What institutional investors are buying Stereotaxis Inc. stockFree Buy/Sell Signal Notifications - Jammu Links News
Trendlines Suggest Stereotaxis Inc. May Bottom Out SoonAccurate Buy Point for Momentum Stocks Detected - metal.it
Stereotaxis Inc.’s volatility index tracking explainedFree Reliable Alerts for Daily Stock Movers - Newser
What are Stereotaxis Inc. company’s key revenue driversAI Powered Growth Plan For 2025 - Jammu Links News
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared - MedTech Dive
Stereotaxis Inc. Q2 Earnings Preview: Revenue Up 76.7%, EPS Unchanged - AInvest
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Is Stereotaxis Inc. stock bottoming outReliable Alerts for Daily Stock Movers Released - metal.it
Why did STXS revenue surge in Q3 2024 despite rising expenses? - AInvest
How does Stereotaxis Inc. generate profit in a changing economySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Navigating STXS’s Stock Market Maze: Ups and Downs in 2025 - investchronicle.com
Stereotaxis' MAGiC Sweep: A Strategic Inflection Point in Robotic Electrophysiology - AInvest
Stereotaxis wins FDA clearance for diagnostic mapping catheter - Yahoo Finance
Stereotaxis' FDA-Cleared MAGiC Sweep Catheter: A Catalyst for Growth in the Robotic Ablation Era - AInvest
Stereotaxis Wins FDA Nod for MAGiC Sweep EP Catheter - Medical Product Outsourcing
Stereotaxis stock soars after FDA clearance for robotic mapping catheter By Investing.com - Investing.com Canada
Stereotaxis receives FDA clearance for robotic mapping catheter By Investing.com - Investing.com Nigeria
Stereotaxis receives FDA clearance for robotic mapping catheter - Investing.com India
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter - GlobeNewswire
Revolutionary Cardiac Mapping Breakthrough: FDA Approves First Robotic High-Density EP Catheter - Stock Titan
When is Stereotaxis Inc. stock expected to show significant growthStay ahead with advanced stock screening tools - Jammu Links News
0.80%
자본화:
|
볼륨(24시간):